Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years
Our experience confirms that MGRS is a heterogeneous disease and adds to the literature concerning the diagnosis and treatment of MGRS. Successful treatment of the underlying hematologic disorder with targeted therapy is more likely to lead to an improvement in kidney function.
Authors
- Kim Cheema
- Chunpeng Nie (ORCID: https://orcid.org/0000-0003-3295-0943)
- Víctor H. Jiménez‐Zepeda (ORCID: https://orcid.org/0000-0002-6220-5955)
- Holly Lee (ORCID: https://orcid.org/0000-0001-8353-0848)
- Jason Tay (ORCID: https://orcid.org/0000-0002-5969-9755)
- Peter Duggan (ORCID: https://orcid.org/0000-0002-1615-2274)
- Paola Neri (ORCID: https://orcid.org/0000-0002-2595-3647)
- Nizar Jacques Bahlis (ORCID: https://orcid.org/0000-0001-7353-7034)
- Sylvia McCulloch
Institutions
- University of Calgary (CA)
Publication Details
- Journal
- Canadian Journal of Kidney Health and Disease
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1177/20543581251318830
- Citations
- 1
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.81